# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA620214 | A | Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose | Macaca mulatta | 1 | ALA1123985 | organism-based format | Scientific Literature | |
2. | ALA620215 | A | Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose | Macaca mulatta | 5 | ALA1123985 | organism-based format | Scientific Literature | |
3. | ALA620216 | A | Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose | Macaca mulatta | 6 | ALA1123985 | organism-based format | Scientific Literature | |
4. | ALA625212 | A | Area under curve was determine after peroral administration at 10 mpk in Rhesus | Macaca mulatta | 1 | ALA1136139 | organism-based format | Scientific Literature | |
5. | ALA625395 | A | Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg | Macaca mulatta | 1 | ALA1130515 | organism-based format | Scientific Literature | |
6. | ALA626077 | A | Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg | Macaca mulatta | 1 | ALA1130515 | organism-based format | Scientific Literature | |
7. | ALA628399 | A | Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey | Macaca mulatta | 2 | ALA1134799 | organism-based format | Scientific Literature | |
8. | ALA625785 | A | Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey | Macaca mulatta | 2 | ALA1134799 | organism-based format | Scientific Literature | |
9. | ALA631429 | A | Intrinsic clearance in Rhesus liver microsome | Macaca mulatta | 1 | ALA1136139 | organism-based format | Scientific Literature | |
10. | ALA631432 | A | Low plasma clearance was calculated in rhesus monkey | Macaca mulatta | 1 | ALA1135129 | organism-based format | Scientific Literature | |
11. | ALA876431 | A | Plasma clearance after peroral administration at 10 mpk in Rhesus | Macaca mulatta | 1 | ALA1136139 | organism-based format | Scientific Literature | |
12. | ALA625715 | A | Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey | Macaca mulatta | 1 | ALA1129245 | organism-based format | Scientific Literature | |
13. | ALA622808 | A | Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg | Macaca mulatta | 1 | ALA1136692 | organism-based format | Scientific Literature | |
14. | ALA631014 | A | Cmax was determine after peroral administration at 10 mpk in Rhesus | Macaca mulatta | 1 | ALA1136139 | organism-based format | Scientific Literature | |
15. | ALA631459 | A | Terminal half life in Rhesus monkeys at the dose of 30 mg/kg. | Macaca mulatta | 1 | ALA1124865 | organism-based format | Scientific Literature | |
16. | ALA631460 | A | Terminal half life in Rhesus monkeys urine at the dose of 30 mg/kg. | Macaca mulatta | 1 | ALA1124865 | organism-based format | Scientific Literature | |
17. | ALA631461 | A | Terminal half life in Rhesus monkeys at the dose of 30 mg/kg. | Macaca mulatta | 1 | ALA1124865 | organism-based format | Scientific Literature | |
18. | ALA629129 | A | Plasma clearance was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg; No Data | Macaca mulatta | 1 | ALA1130515 | organism-based format | Scientific Literature | |
19. | ALA630632 | A | In vitro plasma protein binding was evaluated by using rhesus monkey at 20 ug/mL | Macaca mulatta | 2 | ALA1127066 | organism-based format | Scientific Literature | |
20. | ALA876190 | A | Plasma concentration after 3 mg/kg intravenous dosing in Rhesus monkey at 0.167 hr | Macaca mulatta | 1 | ALA1129245 | organism-based format | Scientific Literature |